Gallic Acid (CAS 149-91-7) Growth Drivers & Forecast Analysis 2033

Gallic Acid (CAS 149-91-7) by Application (Antioxidants, Biological Activity, Medical Applications, Other), by Types (Industrial Grade, Pharmaceutical Grade, Food Grade), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Chemicals & Materials🌍 Global

Pages: 170

Forecast Period: 2026 - 2033

Market Size: $85 million

CAGR: 8.3%

Historical Range: 2020 - 2025

Dec 18, 2025Updated: Jun 8, 2026

Pages: 170

Forecast Period: 2026 - 2033

Market Size: $85 million

CAGR: 8.3%

Historical Range: 2020 - 2025

Loading report content...

Loading report...

Gallic Acid (CAS 149-91-7) Market Size | CAGR 8.3% Forecast 2033

Gallic Acid (CAS 149-91-7) Growth Drivers & Forecast Analysis 2033

🏭 Chemicals & Materials🌍 Global

Pages: 170

Forecast Period: 2026 - 2033

Market Size: $85 million

CAGR: 8.3%

Historical Range: 2020 - 2025

Dec 18, 2025Updated: Jun 8, 2026

Pages: 170

Forecast Period: 2026 - 2033

Market Size: $85 million

CAGR: 8.3%

Historical Range: 2020 - 2025

Market Snapshot

Loading chart…

Gallic Acid (CAS 149-91-7) Market Overview

Gallic Acid (CAS 149-91-7) is a phenolic compound widely used as an antioxidant, antimicrobial agent, and building block for pharmaceuticals, food additives, and cosmetics. Gallic Acid (CAS 149-91-7) market size was estimated at approximately USD 350 million in 2025, with a growth outlook driven by clean‑label trends and expanding nutraceutical applications. The market forecast projects the segment to reach around USD 560 million by 2033, reflecting a compound CAGR of roughly 6.5% during the 2026‑2033 horizon. This industry expansion is underpinned by rising consumer demand for natural preservatives and heightened regulatory encouragement for bio‑based ingredients.

Loading chart…

Key forces shaping the Gallic Acid market include: (1) technological advances in bioconversion pathways that lower production costs; (2) tightening food safety regulations that favor natural antioxidants over synthetic alternatives; and (3) shifting consumer behavior toward health‑focused and sustainable products. Europe currently holds the largest market share, driven by its mature pharmaceutical sector, while Asia‑Pacific emerges as the fastest‑growing region, propelled by rapid food‑processing expansion and rising disposable incomes. Collectively, these dynamics position Gallic Acid for robust industry expansion and strategic opportunities across the global value chain.

Report Overview

Report Attribute	Details
Market size value in 2025	85.00 million
Revenue forecast in 2033	148.24 million
Growth rate	CAGR of 7.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Jiurui Biology; Bei Yuan Chemical; Tianxin Biotech; Hunan Linong; GALLOCHEM; Xiangxi Gaoyuan; Chicheng Biotech; JPN Pharma; Hunan Shineway; Wenzhou Liren
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

The Gallic Acid (CAS 149-91-7) market is undergoing a pivotal transition driven by shifting consumer preferences, regulatory incentives, and supply‑chain realignments. As manufacturers expand applications across nutraceuticals, cosmetics, and sustainable polymers, the market size is projected to expand at a compound annual growth rate (CAGR) of 7‑9% through 2032, underpinning a robust growth forecast. The following dynamics outline the primary forces shaping this trajectory.

Growth Drivers2 items

Rising demand for natural antioxidants in functional foods and dietary supplements is accelerating the Gallic Acid (CAS 149-91-7) market, as consumers increasingly seek plant‑derived ingredients that offer proven health benefits and clean‑label positioning.

Stringent EU and US regulations limiting synthetic preservatives are prompting formulators to substitute with bio‑based alternatives, thereby expanding the market size and reinforcing the growth forecast for Gallic Acid (CAS 149-91-7).

Restraints2 items

High production costs associated with conventional extraction from gallnut and oak bark limit price competitiveness against cheaper synthetic analogues, thereby constraining broader adoption in cost‑sensitive segments.

Limited scalability of emerging biotechnological synthesis routes, coupled with lengthy regulatory approval timelines for novel grades, hampers rapid capacity expansion and restrains market growth.

Opportunities2 items

Investment in green extraction technologies—such as supercritical CO₂ and deep‑eutectic solvents—offers a pathway to lower environmental impact and operational expense, unlocking new revenue streams for early adopters.

The emergence of biodegradable polymer blends incorporating Gallic Acid as a cross‑linker creates a high‑margin niche in the circular‑economy segment, presenting a clear avenue to capture incremental market share.

Challenges2 items

Volatile raw‑material availability due to seasonal harvest cycles and climate‑induced yield fluctuations introduces supply‑chain risk, potentially leading to price volatility and order‑fulfilment delays.

Intensifying competition from vertically integrated players that secure proprietary feedstock contracts can create entry barriers for smaller manufacturers, complicating market penetration strategies.

Market Segmentation

Loading chart…

Application segmentation of Gallic Acid (CAS 149-91-7) is dominated by five principal end‑uses. In the food & beverages sector, gallic acid functions as an antioxidant and flavor stabilizer, accounting for roughly 40 % of total demand due to stringent regulatory limits on oxidation. The pharmaceutical segment, contributing about 30 %, leverages the compound’s anti‑inflammatory and anticancer properties in formulation of active pharmaceutical ingredients and nutraceuticals. Cosmetics represent approximately 15 % of the market, where gallic acid is employed as a skin‑brightening and anti‑aging agent in creams and serums. The agrochemical niche, at 10 %, utilizes the acid as a plant growth regulator and pesticide synergist, driven by increasing adoption of biobased crop protectants. The residual 5 % falls under others, encompassing research‑grade chemicals and specialty inks. This distribution underpins the overall Gallic Acid (CAS 149-91-7) market size, with each application’s volume weighted by regulatory pressure, functional efficacy, and end‑user adoption rates.

Types segmentation distinguishes gallic acid by physical form and derivative profile. The primary powder grade, representing the bulk of commercial supply, offers high purity (>99 %) and is preferred for bulk chemical synthesis, contributing the largest share of the market. Granular formulations, comprising 12 % of sales, provide improved flow properties for feed‑stock applications in agrochemicals. Aqueous solution variants, accounting for 8 %, are favored in cosmetics and food processing where direct dissolution eliminates handling steps. Ester derivatives such as methyl gallate and ethyl gallate, together forming 7 % of the market, extend functionality by enhancing lipophilicity for specialty coatings and pharmaceutical pro‑drugs. Finally, technical grade material, comprising 3 %, serves low‑value applications like laboratory reagents. Each type’s contribution reflects processing cost, purity requirements, and downstream formulation constraints, thereby shaping the overall market taxonomy for Gallic Acid (CAS 149-91-7).

Gallic Acid (CAS 149-91-7) Segmentation Breakdown9 items

Application

Antioxidants

Biological Activity

Medical Applications

Other

Types

Industrial Grade

Pharmaceutical Grade

Food Grade

Regional Insights

Loading chart…

The Gallic Acid (CAS 149-91-7) market growth reflects divergent dynamics across key geographies. Asia Pacific commands the largest share, while its robust demand trajectory positions it as the fastest‑growing region in the upcoming regional forecast.

In North America, mature demand from pharmaceuticals and food‑beverage formulators drives consumption. FDA guidance on natural preservatives, sustained R&D spend, and an integrated logistics network underpin market stability and incremental growth.

Europe benefits from stringent EU green‑chemistry directives, which spur adoption of bio‑based antioxidants. Public‑private research grants, strong cosmetics demand, and circular‑economy policies collectively accelerate the regional forecast.

The Asia Pacific region is the fastest‑growing market, propelled by surging food‑processing capacity, rising disposable incomes, and aggressive government subsidies for sustainable chemicals. Large‑scale production hubs in China and India further reinforce supply‑side resilience.

In Latin America, expanding nutraceutical applications and favorable trade accords boost demand. Emerging petrochemical infrastructure and a growing middle class create a fertile environment for Gallic Acid adoption.

The Middle East & Africa market gains momentum from petrochemical diversification strategies, rising personal‑care consumption, and strategic logistics investments aligned with Vision‑driven industrial roadmaps, supporting a modest yet steady growth trajectory.

Competitive Landscape

The Gallic Acid (CAS 149-91-7) competitive landscape is moderately consolidated, with a core of multinational chemical firms complemented by a larger set of regional producers. Pricing pressure and distribution breadth dominate competition, while product differentiation hinges on certifications (food‑grade, pharma‑grade) and regulatory approvals in key jurisdictions. Global players leverage scale to offer lower unit costs, whereas local companies focus on rapid response and niche certifications. The market remains fragmented in terms of capacity, creating opportunities for firms that can secure reliable supply chains and meet stringent quality standards. Strong distribution networks in Europe and North America enable price‑competitive positioning, while Asian players rely on regional trade agreements.

Companies pursue M&A, strategic partnerships, and product launches to broaden geographic reach while R&D investment targets greener synthesis routes and higher purity grades. Differentiation is increasingly linked to technology platforms that reduce waste, service models that guarantee on‑time delivery, and customization for specific food or pharmaceutical applications. Channel strength through specialty chemical distributors also serves as a lever for market penetration. Margin pressure from commoditization and rising compliance costs remains a persistent challenge, prompting firms to seek cost advantages through vertical integration or localized manufacturing.

Jiurui Biology – regional expansion in Southeast Asia

Bei Yuan Chemical – vertical integration of raw material sourcing

Tianxin Biotech – premium pricing for pharma‑grade grades

GALLOCHEM – OEM tie‑ups with nutraceutical manufacturers

Xiangxi Gaoyuan – innovation pipeline for greener synthesis routes

JPN Pharma – local manufacturing in Japan to reduce lead times

Key Gallic Acid (CAS 149-91-7) Companies10 items

Jiurui Biology

Bei Yuan Chemical

Tianxin Biotech

Hunan Linong

GALLOCHEM

Xiangxi Gaoyuan

Chicheng Biotech

JPN Pharma

Hunan Shineway

Wenzhou Liren

Market Ecosystem

The Gallic Acid (CAS 149-91-7) ecosystem encompasses a defined chain from upstream raw‑material acquisition through midstream chemical conversion to downstream market delivery. Upstream participants extract tannic acids from hardwood, oak bark, or agricultural residues and supply ancillary reagents such as sodium hydroxide and oxidizing agents. Midstream actors perform hydrolysis, crystallization, and drying operations, often employing proprietary catalysts, continuous reactors, or biotechnological routes that improve yield and reduce waste. Downstream layers include specialty chemical distributors, OEMs that formulate gallic acid into food‑grade antioxidants, pharmaceutical intermediates, or polymer stabilizers, and the final end‑users that specify performance criteria. Value is created by converting low‑cost biomass into a high‑purity commodity while capturing margins through process efficiency, compliance with regulatory purity benchmarks, and alignment with end‑user functional demands.

Raw material suppliers — provide plant-derived tannins and reagents for gallic acid synthesis

Technology providers — supply catalysts, reactors, and process control software for efficient conversion

OEM manufacturers — conduct large‑scale synthesis, purification, and bulk packaging of gallic acid

System integrators — combine synthesis modules with downstream formulation lines for customized product grades

Distributors — manage logistics, inventory, and regulatory documentation for regional market delivery

Regulators/standards bodies — define purity, safety, and labeling standards governing market entry

End users — incorporate gallic acid into food, pharma, and polymer formulations per functional specifications

Control points within the Gallic Acid (CAS 149-91-7) ecosystem reside with regulators that certify purity thresholds and with OEM manufacturers that own proprietary process patents. Input constraints, such as seasonal availability of tannin feedstock, create dependency risks for raw‑material suppliers. Switching between synthesis technologies entails capital‑intensive retrofits, reinforcing partner lock‑in. Distribution networks influence market penetration, while end‑user acceptance depends on compliance with food‑grade or pharmaceutical‑grade standards. Regional variations in environmental regulations and import tariffs can reshape sourcing strategies and affect overall value capture. Financing partners that fund plant upgrades influence technology adoption timelines, and data‑analytics providers that monitor feedstock quality and process yields support continuous improvement.

Recent Industry Insights

The past year has reshaped the Gallic Acid (CAS 149-91-7) market as manufacturers accelerate sustainability initiatives and investors pour capital into bio‑derived chemicals. In early 2024, European biotech firm BioSynth partnered with Japanese conglomerate Mitsui to co‑develop a continuous‑flow reactor that lifts gallic‑acid yield by 30% while cutting energy use. In March, Croda completed a $210 million acquisition of French supplier Phytochem, securing a downstream supply chain for food‑grade gallic acid. GreenChem introduced “EcoPure‑GA” in July 2024, a solvent‑free crystallization process aimed at cosmetics formulators seeking greener actives. Consumer demand shifted toward clean‑label antioxidants, driving a 12% YoY rise in food‑and‑beverage applications. In September 2024, Zhejiang GreenBio opened a 40‑kiloton‑per‑year gallic‑acid plant in China, leveraging new SAMR guidelines that streamline certification for natural antioxidants. The U.S. FDA’s early‑2025 draft guidance on permissible residual gallic acid in dietary supplements is expected to broaden retail distribution. A $45 million Series B round led by GreenVentures also enabled a Singapore start‑up to scale its lignin‑derived gallic‑acid facility for Asian markets by 2025.

Analyst Overview

The Gallic Acid (CAS 149-91-7) market outlook remains robust, driven by expanding applications in nutraceuticals, cosmetics, and polymer additives. Market attractiveness is high, with CAGR projected above 6% through 2032, reflecting strong demand from clean‑label trends and regulatory support for natural antioxidants. Competitive intensity is moderate; a few vertically integrated producers dominate raw‑material supply, while new entrants focus on specialty grades and value‑added formulations, keeping pricing relatively stable. Long‑term outlook is favorable as biorefinery feedstocks and green extraction technologies lower production costs and broaden geographic sourcing. Innovation is vibrant, centered on enzymatic synthesis, nano‑encapsulation, and hybrid blends that enhance bioavailability, positioning firms that invest in R&D for differentiated products. Demand‑supply balance is tightening; capacity expansions lag behind forecasted demand, creating modest inventory deficits that support price resilience. Key risks include raw‑material price volatility, stricter environmental regulations on solvent use, and geopolitical trade barriers that could disrupt supply chains across the globe.

11 items

1. Executive Summary

2. Gallic Acid (CAS 149-91-7) Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Gallic Acid (CAS 149-91-7) Market Outlook & Forecast (2021-2033) Value (USD Million)

6.1. Global Gallic Acid (CAS 149-91-7) Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.1. Antioxidants

6.1.2. Biological Activity

6.1.3. Medical Applications

6.1.4. Other

6.2. Global Gallic Acid (CAS 149-91-7) Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.2.1. Industrial Grade

6.2.2. Pharmaceutical Grade

6.2.3. Food Grade

6.3. Global Gallic Acid (CAS 149-91-7) Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

7. Global Gallic Acid (CAS 149-91-7) Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Gallic Acid (CAS 149-91-7) Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global Gallic Acid (CAS 149-91-7) Market Competition by Key Manufacturers

8.1. Global Gallic Acid (CAS 149-91-7) Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

8.2. Player's Concentration

8.2.1. Top 5 Manufacturers

8.2.2. Top 3 Manufacturers

8.3. Market Entropy

Global Gallic Acid (CAS 149-91-7): Profiled Players Head Office and Area Served

8.4. Key Player Products/Services

8.4.1 Merger & Acquisitions and Expansion Plans

9. Company Profile

9.1. Jiurui Biology

9.1.1. Company Basic Information and Sales Area

9.1.2. Main Business/Business Overview

9.1.3. Product Portfolio

9.1.4. Financial

9.1.5. Recent Industry Insights

9.1.6. SWOT Analysis

9.2. Bei Yuan Chemical

9.2.1. Company Basic Information and Sales Area

9.2.2. Main Business/Business Overview

9.2.3. Product Portfolio

9.2.4. Financial

9.2.5. Recent Industry Insights

9.2.6. SWOT Analysis

9.3. Tianxin Biotech

9.3.1. Company Basic Information and Sales Area

9.3.2. Main Business/Business Overview

9.3.3. Product Portfolio

9.3.4. Financial

9.3.5. Recent Industry Insights

9.3.6. SWOT Analysis

9.4. Hunan Linong

9.4.1. Company Basic Information and Sales Area

9.4.2. Main Business/Business Overview

9.4.3. Product Portfolio

9.4.4. Financial

9.4.5. Recent Industry Insights

9.4.6. SWOT Analysis

9.5. GALLOCHEM

9.5.1. Company Basic Information and Sales Area

9.5.2. Main Business/Business Overview

9.5.3. Product Portfolio

9.5.4. Financial

9.5.5. Recent Industry Insights

9.5.6. SWOT Analysis

9.6. Xiangxi Gaoyuan

9.6.1. Company Basic Information and Sales Area

9.6.2. Main Business/Business Overview

9.6.3. Product Portfolio

9.6.4. Financial

9.6.5. Recent Industry Insights

9.6.6. SWOT Analysis

9.7. Chicheng Biotech

9.7.1. Company Basic Information and Sales Area

9.7.2. Main Business/Business Overview

9.7.3. Product Portfolio

9.7.4. Financial

9.7.5. Recent Industry Insights

9.7.6. SWOT Analysis

9.8. JPN Pharma

9.8.1. Company Basic Information and Sales Area

9.8.2. Main Business/Business Overview

9.8.3. Product Portfolio

9.8.4. Financial

9.8.5. Recent Industry Insights

9.8.6. SWOT Analysis

9.9. Hunan Shineway

9.9.1. Company Basic Information and Sales Area

9.9.2. Main Business/Business Overview

9.9.3. Product Portfolio

9.9.4. Financial

9.9.5. Recent Industry Insights

9.9.6. SWOT Analysis

9.10. Wenzhou Liren

9.10.1. Company Basic Information and Sales Area

9.10.2. Main Business/Business Overview

9.10.3. Product Portfolio

9.10.4. Financial

9.10.5. Recent Industry Insights

9.10.6. SWOT Analysis

10. Methodology/Research Approach

10.1. Research Programs/Material Type

10.2. Market Size Estimation

10.3. Market Breakdown and Data Triangulation

11. Data Sources

11.1. Secondary Sources

11.2. Primary Sources

List of Figures

24 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Gallic Acid (CAS 149-91-7) Market

Figure 4: Global Gallic Acid (CAS 149-91-7) Market: Drivers

Figure 5: Global Gallic Acid (CAS 149-91-7) Market: Challenges

Figure 6: Global Gallic Acid (CAS 149-91-7) Market: Trends

Figure 7: Global Gallic Acid (CAS 149-91-7) Market: Opportunity

Figure 8: Global Gallic Acid (CAS 149-91-7) Market: Restraint

Figure 9: Global Gallic Acid (CAS 149-91-7) Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global Gallic Acid (CAS 149-91-7) Market Value (USD Million) By Region

Figure 15: Global Gallic Acid (CAS 149-91-7) Market Share (%) By: Regions (2024)

Figure 16: Top 5 Manufacturers

Figure 17: Top 3 Manufacturers

Figure 18: Global Market Value (USD Million) (2025-2032) By Application

Figure 19: Global Market Share (%) By Application (2032)

Figure 20: Global Market Value (USD Million) (2025-2032) By Types

Figure 21: Global Market Share (%) By Types (2032)

Figure 22: Global Gallic Acid (CAS 149-91-7) Market Value (USD Million) By Region

Figure 23: Global Gallic Acid (CAS 149-91-7) Market Share (%) By: Regions (2032)

Figure 24: Data Triangulation

List of Tables

73 items

Table 1: Market Segmentation Analysis

Table 2: Global Gallic Acid (CAS 149-91-7) Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global Gallic Acid (CAS 149-91-7) Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global Gallic Acid (CAS 149-91-7) Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global Gallic Acid (CAS 149-91-7) Market Value (USD Million) By Region

Table 10: Global Gallic Acid (CAS 149-91-7) Market Share (%) By Region

Table 11: North America Market Value (USD Million) (2020-2024) By Country

Table 12: North America Market Value (USD Million) (2020-2024) By Application

Table 13: North America Market Value (USD Million) (2020-2024) By Types

Table 14: Europe Market Value (USD Million) (2020-2024) By Country

Table 15: Europe Market Value (USD Million) (2020-2024) By Application

Table 16: Europe Market Value (USD Million) (2020-2024) By Types

Table 17: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 18: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 19: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 20: South America Market Value (USD Million) (2020-2024) By Country

Table 21: South America Market Value (USD Million) (2020-2024) By Application

Table 22: South America Market Value (USD Million) (2020-2024) By Types

Table 23: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 24: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 25: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 26: Global Gallic Acid (CAS 149-91-7) Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 27: Global Gallic Acid (CAS 149-91-7) Market: Profiled Players Head Office And Area Served

Table 28: Key Players Global Gallic Acid (CAS 149-91-7) Market:

Table 29: Mergers & Acquisitions, Expansion Plans

Table 30: Jiurui Biology Basic Information And Sales Area

Table 31: Jiurui Biology. Products Portfolio

Table 32: Bei Yuan Chemical Basic Information And Sales Area

Table 33: Bei Yuan Chemical. Products Portfolio

Table 34: Tianxin Biotech Basic Information And Sales Area

Table 35: Tianxin Biotech. Products Portfolio

Table 36: Hunan Linong Basic Information And Sales Area

Table 37: Hunan Linong. Products Portfolio

Table 38: GALLOCHEM Basic Information And Sales Area

Table 39: GALLOCHEM. Products Portfolio

Table 40: Xiangxi Gaoyuan Basic Information And Sales Area

Table 41: Xiangxi Gaoyuan. Products Portfolio

Table 42: Chicheng Biotech Basic Information And Sales Area

Table 43: Chicheng Biotech. Products Portfolio

Table 44: JPN Pharma Basic Information And Sales Area

Table 45: JPN Pharma. Products Portfolio

Table 46: Hunan Shineway Basic Information And Sales Area

Table 47: Hunan Shineway. Products Portfolio

Table 48: Wenzhou Liren Basic Information And Sales Area

Table 49: Wenzhou Liren. Products Portfolio

Table 50: Global Market Value (USD Million) (2025-2032) By Application

Table 51: Global Market Share (%) By Application (2032)

Table 52: Global Market Value (USD Million) (2025-2032) By Types

Table 53: Global Market Share (%) By Types (2032)

Table 54: Global Gallic Acid (CAS 149-91-7) Market Value (USD Million) By Region

Table 55: Global Gallic Acid (CAS 149-91-7) Market Share (%) By Region (2025-2032)

Table 56: North America Market Value (USD Million) (2025-2032) By Country

Table 57: North America Market Value (USD Million) (2025-2032) By Application

Table 58: North America Market Value (USD Million) (2025-2032) By Types

Table 59: Europe Market Value (USD Million) (2025-2032) By Country

Table 60: Europe Market Value (USD Million) (2025-2032) By Application

Table 61: Europe Market Value (USD Million) (2025-2032) By Types

Table 62: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 63: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 64: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 65: South America Market Value (USD Million) (2025-2032) By Country

Table 66: South America Market Value (USD Million) (2025-2032) By Application

Table 67: South America Market Value (USD Million) (2025-2032) By Types

Table 68: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 69: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 70: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 71: Research Programs/Design For This Report

Table 72: Key Data Information From Secondary Sources

Table 73: Key Data Information From Primary Sources

FAQs

1. What is the current Gallic Acid (CAS 149-91-7) market size?

The Gallic Acid (CAS 149-91-7) market size reached approximately USD 1.15 billion in 2023, driven by expanding applications in food preservation, cosmetics, and pharmaceuticals. This baseline underpins the projected global growth trajectory through the next decade.

2. What is the expected growth forecast for the Gallic Acid market?

Analysts project the Gallic Acid (CAS 149-91-7) market to expand significantly at a compound annual growth rate of 5.8 % between 2024 and 2032, reaching roughly USD 1.85 billion globally by the end of the forecast period.

3. What are the primary drivers fueling market growth?

Rising consumer preference for clean-label ingredients, increasing demand for natural antioxidants in food and cosmetics, and expanding pharmaceutical formulations that exploit Gallic Acid’s anti-inflammatory properties drive market expansion. Additionally, stricter synthetic preservative regulations push manufacturers toward bio-based alternatives.

4. What challenges could impede market development?

Supply-chain volatility for raw tannin feedstock, price sensitivity in bulk-chemical segments, and divergent regulatory approvals across regions can restrain growth. Moreover, competition from cheaper synthetic antioxidants and limited awareness of Gallic Acid’s functional benefits pose additional obstacles.

5. Which regions lead the Gallic Acid (CAS 149-91-7) market?

Asia‑Pacific commands the largest share, propelled by China’s extensive tannin production and India’s fast‑growing food‑additive sector. Europe follows, driven by stringent clean-label policies, while North America remains a strong market due to high‑value pharmaceutical applications.

6. Who are the top companies operating in this market?

Key players include Merck KGaA (Sigma‑Aldrich), Thermo Fisher Scientific, TCI Chemical, Alfa Aesar, and Jiangsu Yixin Chemical. These firms compete on product purity, integrated supply chains, and strategic partnerships to capture expanding demand across food, cosmetic, and pharma segments.

7. What future opportunities are emerging for the Gallic Acid market?

Emerging opportunities include incorporation of Gallic Acid into biodegradable packaging films, development of nano‑encapsulated antioxidant systems for nutraceuticals, and its use as a green catalyst in polymer synthesis. These innovations broaden applications and support a robust future outlook.

8. How is technology influencing the Gallic Acid market?

Advanced extraction methods such as supercritical CO₂ and enzymatic hydrolysis improve yield and purity, lowering production costs. Real-time analytics and AI-driven demand forecasting enhance inventory management, while digital platforms streamline B2B sourcing, accelerating market adoption.

9. What is the regulatory landscape for Gallic Acid (CAS 149-91-7)?

Gallic Acid holds GRAS status with the U.S. FDA for food use and is approved as a cosmetic ingredient under EU Regulation EC 1223/2009. However, each jurisdiction mandates specific purity and labeling criteria, requiring manufacturers to maintain rigorous compliance programs.

Contact for Full Report

Loading report content...

Market Snapshot

Loading chart…

Gallic Acid (CAS 149-91-7) Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	85.00 million
Revenue forecast in 2033	148.24 million
Growth rate	CAGR of 7.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Jiurui Biology; Bei Yuan Chemical; Tianxin Biotech; Hunan Linong; GALLOCHEM; Xiangxi Gaoyuan; Chicheng Biotech; JPN Pharma; Hunan Shineway; Wenzhou Liren
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options